Contact us

513 Results:

Sort By:

Prolacta Bioscience Provides Update on Latest SARS-CoV-2 Data and Continued Safety of Its Human Milk-Based Nutritional Products

Type: Press Releases

Topic(s): Quality & Safety

Synova Webinar: Human Donor Milk Safety, A Nurse Leadership Call to Action

Type: Events

Topic(s): Feeding Protocols Healthcare Professionals Pasteurization Quality & Safety

CE Webinar: Human Milk: A Source of Life More Than We Imagined

Type: Events

Topic(s): Conferences and Events Healthcare Professionals

Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis

Prolacta Bioscience Fortifiers Reduce Risk of Serious Lung Disease and Hospital Costs Among Premature Infants, Compared to Cow Milk-Based Fortifiers

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD)

Dr. Melinda Elliott Discusses the Nutritional Needs of Premature Infants in the NICU

Type: Prolacta in the News

Topic(s): Parents

CE Webinar: The Clinical Story of the Exclusive Human Milk Diet

Type: Events

Topic(s): Feeding Protocols

CE Webinar: Golden Hour (and Beyond)

Type: Events

Topic(s):

CE Webinar: Clinical Benefits and Science Behind the Exclusive Human Milk Diet

Type: Events

Topic(s):

Not finding the reference you’re looking for?

Email us at info@prolacta.com